1. Home
  2. RICK vs LYEL Comparison

RICK vs LYEL Comparison

Compare RICK & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RCI Hospitality Holdings Inc.

RICK

RCI Hospitality Holdings Inc.

N/A

Current Price

$28.77

Market Cap

196.2M

ML Signal

N/A

Logo Lyell Immunopharma Inc.

LYEL

Lyell Immunopharma Inc.

N/A

Current Price

$16.92

Market Cap

195.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RICK
LYEL
Founded
1983
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
196.2M
195.8M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
RICK
LYEL
Price
$28.77
$16.92
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
★ $38.38
AVG Volume (30 Days)
30.2K
★ 220.6K
Earning Date
08-06-2026
11-04-2026
Dividend Yield
★ 1.11%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.16
N/A
Revenue
★ $144,896,000.00
$36,000.00
Revenue This Year
$16.98
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$181.22
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$20.76
$7.20
52 Week High
$32.00
$45.00

Technical Indicators

Market Signals
Indicator
RICK
LYEL
Relative Strength Index (RSI) 58.34 79.50
Support Level $25.21 $15.49
Resistance Level $29.32 $16.97
Average True Range (ATR) 1.04 1.28
MACD 0.23 0.82
Stochastic Oscillator 61.25 98.80

Price Performance

Historical Comparison
RICK
LYEL

About RICK RCI Hospitality Holdings Inc.

RCI Hospitality Holdings Inc through its subsidiaries, owns and operates establishments that offer live adult entertainment, restaurant, and or bar operations. It also owns and operates a communication company serving the adult nightclub industry. The company's operating business segments are Nightclubs, Bombshells, and Others. It operates nightclubs through the following brands Rick's Cabaret, Vivid Cabaret, Tootsie's Cabaret, Club Onyx, and Jaguars Club. In the Bombshells segment, the company is building a chain of Restaurants and Sports Bars in Dallas, Austin, and Houston, Texas. It derives the majority of revenue from the Nightclubs segment that engages in the sale of alcoholic beverages, food, and merchandise items; service in the form of cover charges, and room rentals.

About LYEL Lyell Immunopharma Inc.

Lyell Immunopharma Inc s a late-stage clinical cell therapy company advancing a pipeline of proprietary next-generation autologous chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. The Company's product candidate, rondecabtagene autoleucel (ronde-cel, also known as LYL314), is an autologous dual-targeting CD19/CD20 CAR T-cell therapy in development for large B-cell lymphoma (LBCL). The Company has recently acquired exclusive rights outside of mainland China, Hong Kong, Macau and Taiwan, to a novel guanylyl cyclase C (GCC)-targeted CAR T-cell product candidate in early clinical development for refractory metastatic colorectal cancer (mCRC) and other GCC-expressing cancers.

Share on Social Networks: